Gabbroral (Gabroral)
Gabbroral (also known as Gabroral) is an aminoglycoside antibiotic containing paromomycin sulfate, used primarily for intestinal infections. Historically, it has been prescribed for:
- Intestinal amebiasis
- Giardiasis
- Tapeworm infections
The drug acts locally in the gastrointestinal tract with minimal systemic absorption, reducing ammonia-producing bacteria.
Although Gabbroral is absent from the U.S. Food and Drug Administration (FDA) Orange Book and European Medicines Agency’s (EMA) central database, it may still be marketed under national authorizations in some regions, including:
- Belgium
- Luxembourg
- Egypt
- Kenya
- Uganda
In the USA, paromomycin is available only as generics following discontinuation of the Humatin brand.
By Megan Lee
Developed by EPG Health for Medthority, independently of any sponsor.
of interest
are looking at
saved
next event
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
